Photodynamic cancer therapy using liposomes as an advanced vesicular photosensitizer delivery system

J Control Release. 2021 Nov 10:339:75-90. doi: 10.1016/j.jconrel.2021.09.024. Epub 2021 Sep 22.

Abstract

The multidisciplinary field of photodynamic therapy (PDT) is a combination of photochemistry and photophysics sciences, which has shown tremendous potential for cancer therapy application. PDT employs a photosensitizing agent (PS) and light to form cytotoxic reactive oxygen species and subsequently oxidize light-exposed tissue. Despite numerous advantages of PDT and enormous progress in this field, common PSs are still far from ideal treatment because of their poor permeability, non-specific phototoxicity, side effects, hydrophobicity, weak bioavailability, and tendency to self-aggregation. To circumvent these limitations, PS can be encapsulated in liposomes, an advanced drug delivery system that has demonstrated the ability to enhance drug permeability into biological membranes and loading both hydrophobic and lipophilic agents. Moreover, liposomes can also be coated by targeting agents to improve delivery efficiency. The present review aims to summarize the principles of PDT, various PS generations, PS-loaded nanoparticles, liposomes, and their impact on PDT, then discuss recent photodynamic cancer therapy strategies using liposomes as PS-loaded vectors, and highlight future possibilities and perspectives.

Keywords: Drug delivery systems; Liposome; Nanomedicine; Nanoparticle; Photodynamic therapy.

Publication types

  • Review

MeSH terms

  • Humans
  • Liposomes / therapeutic use
  • Nanoparticles*
  • Neoplasms* / drug therapy
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use

Substances

  • Liposomes
  • Photosensitizing Agents